Literature DB >> 27346669

Making it personal: the prospects for autologous pluripotent stem cell-derived therapies.

Nicholas F Blair1,2, Roger A Barker1,2.   

Abstract

Entities:  

Keywords:  cell therapy; induced pluripotent stem cells; technology platforms

Mesh：

Year:  2016        PMID： 27346669     DOI： 10.2217/rme-2016-0057

Source DB:  PubMed          Journal:  Regen Med        ISSN： 1746-0751            Impact factor:   3.806


× No keyword cloud information.
  4 in total

Review 1.  Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy.

Authors:  Martin W Nicholson; Chien-Yu Ting; Darien Z H Chan; Yu-Che Cheng; Yi-Chan Lee; Ching-Chuan Hsu; Ching-Ying Huang; Patrick C H Hsieh
Journal:  Cells       Date:  2022-06-06       Impact factor: 7.666

Review 2.  Genomic Instability of iPSCs: Challenges Towards Their Clinical Applications.

Authors:  Masahito Yoshihara; Yoshihide Hayashizaki; Yasuhiro Murakawa
Journal:  Stem Cell Rev Rep       Date:  2017-02       Impact factor: 5.739

3.  Recent Trends in Research with Human Pluripotent Stem Cells: Impact of Research and Use of Cell Lines in Experimental Research and Clinical Trials.

Authors:  Anke Guhr; Sabine Kobold; Stefanie Seltmann; Andrea E M Seiler Wulczyn; Andreas Kurtz; Peter Löser
Journal:  Stem Cell Reports       Date:  2018-07-19       Impact factor: 7.765

4.  hESC-derived immune suppressive dendritic cells induce immune tolerance of parental hESC-derived allografts.

Authors:  Dilyana Todorova; Yue Zhang; Qu Chen; Jingfeng Liu; Jingjin He; Xuemei Fu; Yang Xu
Journal:  EBioMedicine       Date:  2020-11-23       Impact factor: 8.143
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.